Literature DB >> 22095030

Regulation of p53 by ING family members in suppression of tumor initiation and progression.

Seyed Mehdi Jafarnejad1, Gang Li.   

Abstract

The INhibitor of Growth (ING) family is an evolutionarily conserved set of proteins, implicated in suppression of initiation and progression of cancers in various tissues. They promote cell cycle arrest, cellular senescence and apoptosis, participate in stress responses, regulate DNA replication and DNA damage responses, and inhibit cancer cell migration, invasion, and angiogenesis of the tumors. At the molecular level, ING proteins are believed to participate in chromatin remodeling and transcriptional regulation of their target genes. However, the best known function of ING proteins is their cooperation with p53 tumor suppressor protein in tumor suppression. All major isoforms of ING family members can promote the transactivition of p53 and the majority of them are shown to directly interact with p53. In addition, ING proteins are thought to interact with and modulate the function of auxiliary members of p53 pathway, such as MDM2, ARF , p300, and p21, indicating their widespread involvement in the regulation and function of this prominent tumor suppressor pathway. It seems that p53 pathway is the main mechanism by which ING proteins exert their functions. Nevertheless, regulation of other pathways which are not relevant to p53, yet important for tumorigenesis such as TGF-β and NF-κB, by ING proteins is also observed. This review summarizes the current understanding of the mutual interactions and cooperation between different members of ING family with p53 pathway and implications of this cooperation in the suppression of cancer initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22095030     DOI: 10.1007/s10555-011-9329-5

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  18 in total

1.  Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells.

Authors:  Tatyana S Nekova; Susanne Kneitz; Hermann Einsele; Gernot Stuhler
Journal:  Cell Cycle       Date:  2014-05-20       Impact factor: 4.534

Review 2.  PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy.

Authors:  Gloria Irene Manfredi; Alessandra Dicitore; Germano Gaudenzi; Michele Caraglia; Luca Persani; Giovanni Vitale
Journal:  Endocrine       Date:  2014-08-13       Impact factor: 3.633

3.  Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells.

Authors:  Malgorzata Kloc; Neelam Tejpal; Jitinderpal Sidhu; Malathesha Ganachari; Pedro Flores-Villanueva; Nicholas B Jennings; Anil K Sood; Jacek Z Kubiak; Rafik M Ghobrial
Journal:  Folia Histochem Cytobiol       Date:  2012-10-08       Impact factor: 1.698

Review 4.  MicroRNA in pancreatic cancer.

Authors:  Keiichi Yonemori; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-02       Impact factor: 3.172

Review 5.  Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.

Authors:  Abhik Saha; Erle S Robertson
Journal:  Future Microbiol       Date:  2013-03       Impact factor: 3.165

6.  Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.

Authors:  Penny L Berger; Sander B Frank; Veronique V Schulz; Eric A Nollet; Mathew J Edick; Brittany Holly; Ting-Tung A Chang; Galen Hostetter; Suwon Kim; Cindy K Miranti
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

7.  The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.

Authors:  Yang Li; Hui Deng; Lei Lv; Cheng Zhang; Liting Qian; Jun Xiao; Weidong Zhao; Qi Liu; Daming Zhang; Yingwei Wang; Jun Yan; Hongyu Zhang; Yinghua He; Jingde Zhu
Journal:  Oncotarget       Date:  2015-04-30

Review 8.  Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer.

Authors:  Upasana Bedi; Vivek Kumar Mishra; David Wasilewski; Christina Scheel; Steven A Johnsen
Journal:  Oncotarget       Date:  2014-04-30

9.  Chromatin Memory in the Development of Human Cancers.

Authors:  Yixin Yao; Thomas L Des Marais; Max Costa
Journal:  Gene Technol       Date:  2014-08-11

10.  ING3 is essential for asymmetric cell division during mouse oocyte maturation.

Authors:  Shinnosuke Suzuki; Yusuke Nozawa; Satoshi Tsukamoto; Takehito Kaneko; Hiroshi Imai; Naojiro Minami
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.